Pet Diabetes Care Market Expansion Driven by Rising Awareness of Animal Health 2026–2034
Pet diabetes care includes veterinary treatments, glucose monitoring devices, and nutritional management solutions used to manage diabetes in companion animals, particularly dogs and cats. Diabetes requires ongoing monitoring and treatment, making reliable veterinary care essential for maintaining an affected pet's health and quality of life. Common management approaches include insulin therapy, blood glucose monitoring, veterinary consultations, and appropriate dietary adjustments.
According to Fortune Business Insights, the pet diabetes care market was valued at USD 2.32 billion in 2025 & is projected to grow from USD 2.53 billion in 2026 to USD 5.04 billion by 2034, exhibiting a compound annual growth rate CAGR of 9.02% during the forecast period.
Why Is the Pet Diabetes Care Market Growing?
The market is growing as awareness of diabetes in companion animals increases and veterinary professionals focus on early diagnosis and long-term disease management. Diabetes can affect both dogs and cats, requiring continued treatment, glucose monitoring, and regular veterinary assessments. These ongoing needs create recurring demand for veterinary medicines and monitoring products.
Increasing pet ownership and the humanization of pets are also supporting market expansion. Many owners view companion animals as family members and are willing to invest in treatments that support their health and well-being. This trend is encouraging demand for advanced diagnostic tools, convenient insulin administration, and specialized nutritional products.
Key Market Trends
Growing Adoption of Advanced Glucose Monitoring: Veterinary professionals and pet owners are increasingly interested in glucose monitoring devices that support more consistent diabetes management. Portable meters and continuous monitoring technologies can provide information to guide veterinary decisions and help reduce the burden of repeated testing when appropriate.
Increasing Demand for Veterinary Insulin Treatments: Insulin therapy remains a central component of diabetes management for many affected pets. Demand is supported by increasing diagnosis, ongoing treatment requirements, and the development of products designed for veterinary use.
Greater Focus on Specialized Pet Nutrition: Dietary management is an important part of caring for diabetic pets. Veterinary-recommended nutrition plans and specialized pet foods can help support weight management and consistent feeding routines alongside prescribed treatment.
Expansion of Digital Veterinary Care: Tele-veterinary services, mobile applications, and digital health records are improving communication between pet owners and veterinary professionals. These tools can support follow-up consultations and monitoring, although they do not replace necessary in-person examinations or clinical testing.
Growth of Online Pet Healthcare Distribution: E-commerce platforms and online veterinary pharmacies are making certain diabetes care products more convenient to obtain. Wider digital distribution can improve product access, provided medicines are purchased through legitimate channels and used under appropriate veterinary supervision.
Pet Diabetes Care Market Dynamics
Driver: Rising Prevalence of Diabetes and Growing Pet Healthcare Spending
The increasing need to manage chronic conditions in companion animals is a major driver of the pet diabetes care market. Diabetes requires ongoing attention, including veterinary diagnosis, prescribed medication, glucose monitoring, and dietary management. These continuing needs support demand for treatments and monitoring products.
Restraint: High Costs of Long-Term Diabetes Management
Managing diabetes in pets can involve recurring expenses for insulin, glucose testing supplies, veterinary consultations, and specialized nutrition. These costs may create financial challenges for pet owners, especially when treatment is required over an extended period.
Opportunity: Advanced Monitoring and Connected Veterinary Technologies
Advances in glucose monitoring offer opportunities for veterinary device manufacturers and digital pet healthcare providers. Continuous monitoring systems, portable testing devices, and connected applications can help support the collection and review of glucose information.
Challenge: Treatment Compliance and Early Diagnosis
Diabetes management requires consistent treatment routines, glucose monitoring, and follow-up with veterinary professionals. Some pet owners may find insulin administration or regular testing difficult, which can affect treatment consistency. Recognizing early symptoms and obtaining timely veterinary assessment are also important challenges.
For Detailed Market Insights
Market Segmentation Analysis
The pet diabetes care market is segmented by animal type, solution, distribution channel, and region.
By Animal Type: The market includes dogs and cats. Dogs represent an important segment because canine diabetes often requires ongoing insulin treatment and glucose monitoring. Cats also contribute significantly to demand, with diabetes management involving veterinary supervision, appropriate nutrition, and monitoring. Treatment requirements vary according to the animal's condition and response to therapy.
By Solution: The market includes treatment products and glucose monitoring devices. Treatment products accounted for approximately 64% of the market, supported by recurring demand for insulin-based diabetes management and related veterinary care. Glucose monitoring devices represented approximately 36%, reflecting the importance of tracking glucose levels and supporting treatment decisions.
By Distribution Channel: The market includes e-commerce and other distribution channels through which pet owners obtain veterinary products and diabetes care supplies. E-commerce is gaining importance because it offers convenience and broader product selection. However, prescription medicines and specialized products should be obtained from legitimate suppliers and used according to veterinary instructions.
Regional Insights
North America: North America accounted for 38% of the global pet diabetes care market. High pet ownership, established veterinary infrastructure, and spending on companion animal healthcare support regional demand. Veterinary clinics and animal hospitals provide diagnosis, insulin treatment, and glucose monitoring services, while digital platforms improve access to selected products and follow-up care.
Europe: Europe represented 27% of the market. Growing awareness of companion animal health, established veterinary services, and demand for chronic disease management solutions support regional development. Germany and the United Kingdom are important country markets, with veterinary clinics and pet owners contributing to demand for diabetes treatments and monitoring technologies.
Asia-Pacific: Asia-Pacific accounted for 28% of the global market. Rising pet ownership, expanding veterinary services, and increasing spending on animal health support market growth. Japan is an important market, while China and other countries offer opportunities as access to veterinary diagnostics and chronic disease management services improves.
Rest of the World: The Rest of the World region accounted for 7% of the market. Increasing awareness of pet health and gradual expansion of veterinary services create opportunities across Latin America, the Middle East, and Africa. However, product affordability, access to veterinary specialists, and availability of advanced monitoring technologies may influence adoption.
Competitive Landscape
The pet diabetes care market includes veterinary pharmaceutical companies, diagnostic device manufacturers, and providers of animal healthcare technologies. Competition is influenced by product reliability, treatment effectiveness, ease of use, distribution reach, and relationships with veterinary professionals.
Companies identified by Fortune Business Insights include Merck & Co., Inc., Zoetis, BD, Boehringer Ingelheim International GmbH, Nova Biomedical, Allison Medical, Inc., AccuBioTech Co., Ltd., i-SENS, Inc., and TaiDoc Technology.
Investment Analysis
Investment opportunities are emerging in veterinary pharmaceuticals, glucose monitoring devices, digital pet healthcare, and specialized veterinary services. Companies are developing products intended to improve treatment convenience, monitoring accuracy, and access to ongoing diabetes care.
New Product Development
New product development in the pet diabetes care market focuses on glucose monitoring technologies, veterinary insulin treatments, and digital tools for chronic disease management. Manufacturers are exploring portable testing systems, continuous glucose monitoring approaches, and connected applications that can help users review glucose information with veterinary professionals.
Future Outlook
The pet diabetes care market is expected to grow through 2034 as pet owners increasingly invest in veterinary treatment and long-term management of chronic conditions. The market is projected to increase from USD 2.53 billion in 2026 to USD 5.04 billion by 2034, at a CAGR of 9.02%.
Request Free Sample PDF
What’s Driving Japan’s Market? Discover the Latest Pet Diabetes Care Market Insights
Comments